Jane F. Apperley

Defining the Intensity of Conditioning Regimens: Working Definitions

Andrea Bacigalupo, Karen K. Ballen, Doug Rizzo et al. · Biology of Blood and Marrow Transplantation · 2009 · 1.8K citations · Full text

Medicine, Hematology, Cell Therapy +9

CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION

Joan Bladé, Diana Samson, Donna Reece et al. · British Journal of Haematology · 1998 · 1.5K citations

Medicine, Hematology, Oncology +17

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

Jörge E. Cortes, D. W. Kim, Javier Pinilla‐Ibarz et al. · New England Journal of Medicine · 2013 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +17

Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity

Simone Wahl, Alexander Drong, Benjamin Lehne et al. · Nature · 2016 · 1K citations · Full text

Life Sciences, Bioinformatics, Biostatistics +14

Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib

David Marín, Alexandra Bazeos, François-Xavier Mahon et al. · Journal of Clinical Oncology · 2010 · 901 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13